Tower Research Capital (TRC)’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-583
Closed -$6K 6870
2022
Q3
$6K Sell
583
-631
-52% -$6.27K ﹤0.01% 5110
2022
Q2
$12K Sell
1,214
-283
-19% -$2.79K ﹤0.01% 4342
2022
Q1
$14K Sell
1,497
-4,141
-73% -$40.6K ﹤0.01% 3943
2021
Q4
$55K Buy
5,638
+2,944
+109% +$28.9K ﹤0.01% 2702
2021
Q3
$26K Buy
2,694
+1,248
+86% +$12.2K ﹤0.01% 3503
2021
Q2
$14K Buy
+1,446
New +$14.8K ﹤0.01% 4201

Other funds holding HAAC

Tower Research Capital (TRC)'s HAAC Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 583 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in HAAC in Q2 2021 and held it in 6 quarters. The position peaked at $55K in Q4 2021. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 583 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Health Assurance Acquisition Corp. Class A Common Stock position peaked at $55K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.